Functional and biochemical characteristics of a soluble B lymphocyte proliferation-inhibiting activity produced by bone marrow cells from multiple myeloma patients

Cell Immunol. 1995 May;162(2):275-81. doi: 10.1006/cimm.1995.1079.

Abstract

Several mechanisms are discussed as inducers for polyclonal hypogammaglobulinemia in multiple myeloma. A soluble noncytotoxic activity which inhibits in vitro the proliferation of normal polyclonal spleen B lymphocytes was measured in the supernatant of cultured bone marrow mononuclear cells from multiple myeloma patients. In addition, human B lymphoblastic cell lines (CESS, Daudi) and human T lymphocytes were sensitive to the antiproliferative effect of the suppressor activity, while other cell lines (RPMI 8226, IM9, CTL6, L1210, HL-60, and K562) were not. The activity was detected in a 5-kDa fraction and was stable to heating (30 min, 56 degrees C) and proteolytic enzymes. Extraction experiments using chloroform:methanol (2:1) suggest a lipid character of the suppressor activity.

MeSH terms

  • B-Lymphocytes / immunology*
  • Bone Marrow / pathology
  • Bone Marrow / physiopathology*
  • Humans
  • Immunosuppressive Agents* / chemistry
  • Indomethacin / pharmacology
  • Lymphocyte Activation
  • Masoprocol / pharmacology
  • Multiple Myeloma / immunology*
  • Multiple Myeloma / pathology
  • Solubility
  • Waldenstrom Macroglobulinemia / immunology
  • Waldenstrom Macroglobulinemia / pathology

Substances

  • Immunosuppressive Agents
  • Masoprocol
  • Indomethacin